scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1003097100 |
P356 | DOI | 10.1186/1476-4598-11-36 |
P932 | PMC publication ID | 3442987 |
P698 | PubMed publication ID | 22640878 |
P5875 | ResearchGate publication ID | 225068687 |
P50 | author | James D Brenton | Q30506432 |
David A Tumbarello | Q56544644 | ||
P2093 | author name string | Jillian Temple | |
P2860 | cites work | Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility | Q24306782 |
Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I | Q24312882 | ||
beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice | Q24313409 | ||
Corneal dystrophy-associated R124H mutation disrupts TGFBI interaction with Periostin and causes mislocalization to the lysosome | Q24314753 | ||
Integrin signaling | Q28142010 | ||
Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer | Q28275904 | ||
Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/beta ig-h3) that binds to collagen | Q28305358 | ||
Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta | Q28512724 | ||
Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule | Q29616413 | ||
The fibronectin-binding integrins alpha5beta1 and alphavbeta3 differentially modulate RhoA-GTP loading, organization of cell matrix adhesions, and fibronectin fibrillogenesis | Q30441899 | ||
Structural and phylogenetic analyses of RGD-CAP/beta ig-h3, a fasciclin-like adhesion protein expressed in chick chondrocytes | Q32085744 | ||
Identification of motifs for cell adhesion within the repeated domains of transforming growth factor-beta-induced gene, betaig-h3. | Q33910766 | ||
Identification of motifs in the fasciclin domains of the transforming growth factor-beta-induced matrix protein betaig-h3 that interact with the alphavbeta5 integrin | Q34150937 | ||
RGD peptides released from beta ig-h3, a TGF-beta-induced cell-adhesive molecule, mediate apoptosis | Q34188117 | ||
Identification of the alphavbeta3 integrin-interacting motif of betaig-h3 and its anti-angiogenic effect | Q34191650 | ||
Interactions between cancer stem cells and their niche govern metastatic colonization | Q34239769 | ||
Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway | Q34314493 | ||
Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway. | Q34574099 | ||
TGFBIp/betaig-h3 protein: a versatile matrix molecule induced by TGF-beta | Q34656975 | ||
Chemotaxis of 3T3 and SV3T3 cells to fibronectin is mediated through the cell-attachment site in fibronectin and a fibronectin cell surface receptor | Q36216864 | ||
The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel | Q36289190 | ||
The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells | Q36322653 | ||
Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. | Q36411158 | ||
Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel | Q36920871 | ||
Synergistic control of cell adhesion by integrins and syndecans. | Q36986535 | ||
Secreted protein acidic and rich in cysteine as a regulator of murine ovarian cancer growth and chemosensitivity | Q37004638 | ||
TGFBI deficiency predisposes mice to spontaneous tumor development | Q37147623 | ||
Chromosomal instability determines taxane response | Q37208871 | ||
QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatmen | Q37277114 | ||
Signal co-operation between integrins and other receptor systems | Q37396456 | ||
Variants of the cell recognition site of fibronectin that retain attachment-promoting activity | Q37569976 | ||
The transforming growth factor-beta-inducible matrix protein (beta)ig-h3 interacts with fibronectin | Q38288814 | ||
Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells. | Q39697036 | ||
Cross-talk between integrins and oncogenes modulates chemosensitivity | Q39892683 | ||
Integrin beta3 down-regulates invasive features of ovarian cancer cells in SKOV3 cell subclones | Q39902244 | ||
Integrin cross-talk in endothelial cells is regulated by protein kinase A and protein phosphatase 1. | Q39937527 | ||
Integrin alpha3beta1, a novel receptor for alpha3(IV) noncollagenous domain and a trans-dominant Inhibitor for integrin alphavbeta3. | Q40274571 | ||
Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers | Q40391221 | ||
Optimized expression and refolding of human keratoepithelin in BL21 (DE3). | Q40522879 | ||
Induction and expression of betaig-h3 in pancreatic cancer cells | Q40697571 | ||
TGFBI expression is associated with a better response to chemotherapy in NSCLC. | Q42736218 | ||
Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells | Q43722430 | ||
Purification and structural characterization of transforming growth factor beta induced protein (TGFBIp) from porcine and human corneas. | Q45194844 | ||
Beta ig-h3 induces keratinocyte differentiation via modulation of involucrin and transglutaminase expression through the integrin alpha3beta1 and the phosphatidylinositol 3-kinase/Akt signaling pathway | Q46417420 | ||
Loss of Betaig-h3 protein is frequent in primary lung carcinoma and related to tumorigenic phenotype in lung cancer cells | Q46836540 | ||
De novo expression of the integrin alpha5beta1 regulates alphavbeta3-mediated adhesion and migration on fibrinogen | Q47992377 | ||
Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells. | Q52826677 | ||
Molecular properties of wild-type and mutant betaIG-H3 proteins. | Q53673609 | ||
Covalent and non-covalent interactions of betaig-h3 with collagen VI. Beta ig-h3 is covalently attached to the amino-terminal region of collagen VI in tissue microfibrils. | Q53932209 | ||
Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas. | Q54519787 | ||
Expression and Function of β1 and αvβ3 Integrins in Ovarian Cancer | Q58025816 | ||
One-step purification of recombinant proteins with the 6xHis tag and Ni-NTA resin | Q71190234 | ||
Expression of alpha(v)beta3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas | Q73227590 | ||
Secreted and cell surface genes expressed in benign and malignant colorectal tumors | Q74590931 | ||
Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro | Q77874135 | ||
BIGH3 is overexpressed in clear cell renal cell carcinoma | Q80927686 | ||
BigH3 protein expression as a marker for breast cancer | Q81121554 | ||
Beta ig-h3 interacts directly with biglycan and decorin, promotes collagen VI aggregation, and participates in ternary complexing with these macromolecules | Q82360885 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ovarian cancer | Q172341 |
paclitaxel | Q423762 | ||
P304 | page(s) | 36 | |
P577 | publication date | 2012-05-28 | |
P1433 | published in | Molecular Cancer | Q15724585 |
P1476 | title | ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells | |
P478 | volume | 11 |